← Open Payments lookup

CHRISTINA KARL: Open Payments

NPI 1295493930 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$894 in 36 payments from 10 companies in 2025. Trend: 2023 $562 · 2024 $598 · 2025 $894

Food & beverage: $894
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$256
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$201
Neurocrine BioSciences, Inc.3$161
Otsuka America Pharmaceutical, Inc.3$66
Teva Pharmaceuticals USA, Inc.2$53
Alkermes, Inc.2$43
ABBVIE INC.2$40
Axsome Therapeutics, Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.1$26
Supernus Pharmaceuticals, Inc.1$15

Products named: COBENFY, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, UZEDY, LYBALVI, VRAYLAR, Auvelity.

Industry payments across PA — which companies pay providers there.